Meeting & Congress

PathoQuest to Participate in 7th Bioproduction Congress – Lyon, France | 29-30 Sept. 2022
PathoQuest to Participate in 7th Bioproduction Congress – Lyon, France | 29-30 Sept. 2022

The Bioproduction Congress is the annual event of the biopharmaceutical production sector where stakeholders from Europe gather together to showcase and exchange the latest innovations in bioprocessing. This dynamic event promotes exchanges on the future of biomanufacturing, addresses the current challenges, and showcases new breakthrough solutions.

This event will bring together experts from companies (big pharmas, SME and Startups) and laboratories developing therapeutic candidates as well as leading bioproduction professionals to accelerate therapeutics drugs such as mAbs, vaccines, cell therapy and novel products into commercial manufacturing.

read more
PathoQuest to Participate in IABS 3rd NGS Meeting – Rockville, MD USA | 27-28 Sept. 2022
PathoQuest to Participate in IABS 3rd NGS Meeting – Rockville, MD USA | 27-28 Sept. 2022

This meeting will focus on the recent expansion of scientific data and the current applications of next-generation sequencing technologies for adventitious virus detection in biological products.
This will include presentations on standardization and validation of the technical and bioinformatics steps involved in the NGS workflow and
applications of different NGS strategies for characterization and safety evaluation of biologics, including human and animal
vaccines, as well as gene therapy, and therapeutic products. Current regulatory expectations will be discussed.

read more
PathoQuest to Participate in the CAR-TCR Summit in Boston
PathoQuest to Participate in the CAR-TCR Summit in Boston

The long-standing commercial CAR-T players must unite with the hottest trailblazing industry pioneers to shape and secure the future of cell therapy.
The 7th CAR-TCR Summit returns to Boston in 2022 in person with one goal: to engineer a disease-free world.
Across 4 days of carefully curated sessions, we will gather with 200+ CAR and TCR cell therapy VIPs that will lead you and your peers in discussions about novel allogeneic
approaches with enhanced safety considerations, the latest in vivo gene engineering techniques, and advances in CMC strategies and analytical development to ensure the development of high-quality cell products.

read more
PathoQuest to Participate in CAACB Summer Workshop – Boston, USA| 20-21 July2022
PathoQuest to Participate in CAACB Summer Workshop – Boston, USA| 20-21 July2022

High-throughput sequencing (HTSeq) is of high interest to biopharmaceutical
manufacturers as seen from recent survey results indicating that 81% of CAACB member companies are
currently using or exploring the use of HTSeq for viral safety and the remaining 19% expect to do so in the
future. Despite this significant interest, practical experience in the implementation of HTSeq is not widely
available. To address this gap, we are looking for presentations and case studies sharing practical experiences
with implementing HTSeq for a range of applications.

read more
Exclusive study “Use of NGS to replace animal tests for the viral safety of biologics”
Exclusive study “Use of NGS to replace animal tests for the viral safety of biologics”

The industry needs to bring safer biologics to patient in a more ethical and time effective. Classical viral safety testing approaches often fail to keep pace with the demands faced with new and innovative biomedicines and they have fallen out of favor considering the 3Rs (replacement, reduction, refinement of animal testing). See the calendar in regards with the presentation of the new comparison study between NGS and in vivo.

read more

Click here to learn more about PathoQuest’s Biologics Genomic Service for biopharmaceutical companies.

Connect

 

EnglishFrenchGermanSpanish